Pharma-Bio Serv (PBSV) Net Shares Issued and Repurchased (2012 - 2025)

Pharma-Bio Serv (PBSV) has reported Net Shares Issued and Repurchased for 13 consecutive years, with $80000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased fell 11.11% year-over-year to $80000.0; the trailing twelve-month figure through Oct 2025 stood at $80000.0 (down 11.11% YoY), and the FY2025 full-year result was $80000.0, down 11.11% from the prior year.
• Net Shares Issued and Repurchased fell to $80000.0 in Q4 2025 per PBSV's latest filing, from $90000.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $140000.0 in Q4 2022 and bottomed at $80000.0 in Q4 2021.
• Historically, Net Shares Issued and Repurchased has averaged $94000.0 across 5 years, with a median of $80000.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased surged 75.0% in 2022, then tumbled 42.86% in 2023.
• Over 5 years, Net Shares Issued and Repurchased stood at $80000.0 in 2021, then soared by 75.0% to $140000.0 in 2022, then slumped by 42.86% to $80000.0 in 2023, then gained by 12.5% to $90000.0 in 2024, then slipped by 11.11% to $80000.0 in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $80000.0, $90000.0, and $80000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.